Mycoplasma pneumoniae Infection: An Updated Narrative Review
Abstract
Pneumonia cases in China, which rose sharply from October to November 2023, have received particular attention in the world of health. Chinese authorities said the trigger was not a new pathogen, one of which was Mycoplasma. Mycoplasma pneumoniae is a bacteria that can cause disease by damaging the lining of the respiratory system. Mycoplasma pneumoniae infection can occur in all age groups, especially at school and pre-school age. Most studies report that the age group that most often experiences Mycoplasma pneumoniae infection is those aged over 5 years. The importance of recognizing symptoms and providing adequate therapy is very necessary to treat pneumonia caused by Mycoplasma pneumoniae infection.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.